A detailed history of Cetera Investment Advisers transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 765,846 shares of MRK stock, worth $96.4 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
765,846
Previous 126,974 503.15%
Holding current value
$96.4 Million
Previous $16.8 Million 503.16%
% of portfolio
0.24%
Previous 0.18%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 24, 2024

BUY
$113.24 - $131.95 $72.3 Million - $84.3 Million
638,872 Added 503.15%
765,846 $101 Million
Q1 2024

May 14, 2024

SELL
$113.24 - $131.95 $10.1 Million - $11.7 Million
-88,911 Reduced 41.18%
126,974 $16.8 Million
Q4 2023

Feb 13, 2024

SELL
$100.18 - $109.02 $1.54 Million - $1.67 Million
-15,324 Reduced 6.63%
215,885 $23.5 Million
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $3.82 Million - $4.25 Million
-37,146 Reduced 13.84%
231,209 $23.8 Million
Q2 2023

Aug 09, 2023

SELL
$108.61 - $118.38 $444,106 - $484,055
-4,089 Reduced 1.5%
268,355 $31 Million
Q1 2023

May 15, 2023

SELL
$102.94 - $114.86 $1.41 Million - $1.57 Million
-13,694 Reduced 4.79%
272,444 $29 Million
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $8.81 Million - $11.3 Million
100,709 Added 54.31%
286,138 $31.7 Million
Q3 2022

Nov 10, 2022

SELL
$84.53 - $94.96 $3.56 Million - $4 Million
-42,163 Reduced 18.53%
185,429 $16 Million
Q2 2022

Aug 11, 2022

BUY
$83.49 - $94.64 $1.13 Million - $1.29 Million
13,588 Added 6.35%
227,592 $20.8 Million
Q1 2022

May 13, 2022

BUY
$73.51 - $82.4 $1.49 Million - $1.68 Million
20,337 Added 10.5%
214,004 $17.6 Million
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $675,745 - $846,458
9,349 Added 5.07%
193,667 $14.8 Million
Q3 2021

Nov 16, 2021

BUY
$71.68 - $78.83 $260,771 - $286,783
3,638 Added 2.01%
184,318 $13.8 Million
Q2 2021

Aug 13, 2021

BUY
$70.31 - $77.77 $1.91 Million - $2.11 Million
27,168 Added 17.7%
180,680 $14.1 Million
Q1 2021

May 17, 2021

SELL
$68.86 - $81.11 $856,067 - $1.01 Million
-12,432 Reduced 7.49%
153,512 $11.8 Million
Q4 2020

Feb 17, 2021

BUY
$71.77 - $79.65 $8.86 Million - $9.84 Million
123,490 Added 290.88%
165,944 $13.6 Million
Q3 2020

Nov 13, 2020

BUY
$73.18 - $82.95 $142,554 - $161,586
1,948 Added 4.81%
42,454 $3.52 Million
Q2 2020

Aug 13, 2020

BUY
$70.42 - $80.13 $953,205 - $1.08 Million
13,536 Added 50.19%
40,506 $3.13 Million
Q1 2020

May 08, 2020

BUY
$63.36 - $87.82 $316,419 - $438,573
4,994 Added 22.72%
26,970 $2.08 Million
Q4 2019

Feb 10, 2020

BUY
$77.58 - $87.54 $91,311 - $103,034
1,177 Added 5.66%
21,976 $2 Million
Q3 2019

Nov 06, 2019

SELL
$76.08 - $82.93 $63,222 - $68,914
-831 Reduced 3.84%
20,799 $1.75 Million
Q2 2019

Aug 12, 2019

BUY
$69.84 - $81.59 $186,822 - $218,253
2,675 Added 14.11%
21,630 $1.81 Million
Q1 2019

May 06, 2019

BUY
$69.58 - $79.36 $86,209 - $98,327
1,239 Added 6.99%
18,955 $1.57 Million
Q4 2018

Feb 15, 2019

SELL
$65.24 - $75.71 $57,215 - $66,397
-877 Reduced 4.72%
17,716 $1.36 Million
Q3 2018

Nov 14, 2018

BUY
$57.69 - $67.84 $127,841 - $150,333
2,216 Added 13.53%
18,593 $1.31 Million
Q2 2018

Aug 14, 2018

BUY
$50.83 - $59.72 $22,822 - $26,814
449 Added 2.82%
16,377 $993,000
Q1 2018

May 09, 2018

SELL
$50.96 - $59.23 $155,224 - $180,414
-3,046 Reduced 16.05%
15,928 $865,000
Q4 2017

Feb 08, 2018

SELL
$51.62 - $61.64 $62,821 - $75,015
-1,217 Reduced 6.03%
18,974 $1.07 Million
Q3 2017

Nov 16, 2017

SELL
$58.67 - $63.13 $2,229 - $2,398
-38 Reduced 0.19%
20,191 $1.29 Million
Q2 2017

Aug 17, 2017

SELL
N/A
-28,433 Reduced 58.43%
20,229 $1.29 Million
Q2 2017

Aug 14, 2017

BUY
N/A
48,662
48,662 $3.12 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $319B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.